GlassScriptPhysician profile
Alisa A Funke
NPI 1831229871
$1,503.04
in general payments reported to CMS, 2019-2025
16 companies · $569 in 2025
The $569 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.96 · 2022: $10.23 · 2023: $249 · 2024: $641 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $576.02 | 2023-2025 | |
| Organogenesis INC. | $199.41 | 2024-2025 | Puraply Wound Matrix, Puraply Franchise, Puraply Am |
| Novartis Pharmaceuticals Corporation | $133.12 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $119.85 | 2023-2025 | Winlevi, Absorica Ld |
| Lilly USA, LLC | $87.23 | 2023-2025 | Taltz, Olumiant, Zepbound |
| Kerecis Limited | $75.43 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Janssen Biotech, INC. | $75.31 | 2023-2025 | Tremfya |
| Integra Lifesciences Corporation | $42.32 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Amgen INC. | $42.26 | 2023-2024 | Otezla |
| Incyte Corporation | $36.71 | 2023 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $33.77 | 2025 | Dupixent |
| Genentech USA, INC. | $21.83 | 2019 | |
| Leo Pharma INC. | $17.97 | 2025 | Anzupgo |
| Arcutis Biotherapeutics, INC. | $16.83 | 2025 | Zoryve |
| Ucb, INC. | $14.75 | 2023 | Cimzia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $10.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisa Funke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.